Showing 1 - 10 of 1,096
In October 2002, a substitution reform was introduced in the Swedish pharmaceuticals market. In this paper, the effects …
Persistent link: https://www.econbiz.de/10009240823
the effects of prices, detailing, sampling, journal advertising, time-in-market, and molecule-specific characteristics … effectiveness of advertising and pricing between earlier versus later entrants …
Persistent link: https://www.econbiz.de/10012709667
This paper examines generic entry into the Japanese pharmaceutical market. Relatively little is known about generic entry in regulated markets. Using micro data between 2003 and 2005, I find that generic entry is sensitive to the prescription pattern driven by the price regulation and healthcare...
Persistent link: https://www.econbiz.de/10014210344
We customize the aggregative game approach to oligopoly to study asymmetric media markets. Advertiser, platform, and … platforms use two-sided pricing or consumers like advertising,advertiser and consumer interests are often aligned. …
Persistent link: https://www.econbiz.de/10011491950
competition "either or both." A central result is that platform ownership does not affect advertising levels, despite nontrivial … viewer fees. We show that the equilibrium advertising level is inefficiently high. We also demonstrate that entry of a … platform leads to an increase in the advertising level if viewers' preferences for the platforms are negatively correlated …
Persistent link: https://www.econbiz.de/10010339953
In this paper we study the effect of reference pricing on pharmaceutical prices and expenditures when generic entry is endogenously determined. We develop a Salop-type model where a brand-name producer competes with generic producers in terms of prices. In the market there are two types of...
Persistent link: https://www.econbiz.de/10013024341
press and literature, it is also possible that the adoption of reformulated products is mostly the result of advertising … document significant adoption of the reformulation Ambien CR and show that it is not only driven by advertising. I use these …
Persistent link: https://www.econbiz.de/10014135034
pharmaceuticals to examine how incumbents respond to change in the threat of entry. In line with the entry deterrence motive …
Persistent link: https://www.econbiz.de/10012285099
This paper merges patent citation data with data on pharmaceutical patent expirations, generic entry, and pricing to explore the effects of observable patent characteristics on off-patent and on-patent pharmaceutical pricing. Using a sample of drug patents facing generic entry in the 1990s, I...
Persistent link: https://www.econbiz.de/10012732596
This article uses a temporal discontinuity approach to test for history-dependence in demand for chronic drugs. When quasi-randomly assigned to a particular drug, patients continue to choose it over time and are also more likely to subsequently choose generic versions and line extensions of the...
Persistent link: https://www.econbiz.de/10012850412